Recently, the FABP5 inhibitor dmrFABP5 were illustrated to inhibit the FABP5-PPARγ pathway to suppress the malignant progression of PCa cells (Al-Jameel et al., 2019). This evidence concerns the gene PPARG and posterior cortical atrophy.